REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC AMENDMENT
30/12/2020 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201230:nBw4TmT7Ha&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC AMENDMENT
Ap19
FORM 8.3 Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 21 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,049,699 2.37% 684,939 0.53%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,415,404 2.65% 1,423,944 1.10%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 207.3100 USD
Purchase 2 207.3650 USD
Purchase 2 204.8050 USD
Purchase 2 203.8850 USD
Purchase 3 203.4383 USD
Purchase 4 204.6300 USD
Purchase 5 203.8100 USD
Purchase 6 207.8900 USD
Purchase 7 205.6228 USD
Purchase 30 201.5560 USD
Purchase 30 207.3300 USD
Purchase 38 204.4800 USD
Purchase 57 207.4960 USD
Purchase 91 205.5100 USD
Purchase 100 206.2400 USD
Purchase 100 203.7700 USD
Purchase 104 207.4475 USD
Purchase 105 207.1150 USD
Purchase 107 207.9015 USD
Purchase 142 207.1094 USD
Purchase 156 207.6257 USD
Purchase 192 207.7016 USD
Purchase 213 208.0155 USD
Purchase 219 207.6212 USD
Purchase 226 207.3640 USD
Purchase 281 205.6064 USD
Purchase 300 203.9633 USD
Purchase 308 207.7037 USD
Purchase 347 207.4504 USD
Purchase 400 205.4350 USD
Purchase 400 202.1250 USD
Purchase 609 205.8876 USD
Purchase 891 204.4971 USD
Purchase 923 204.9862 USD
Purchase 1,065 207.7100 USD
Purchase 1,176 203.9268 USD
Purchase 1,415 206.5755 USD
Purchase 1,534 204.5328 USD
Purchase 1,613 206.9122 USD
Purchase 1,705 206.7723 USD
Purchase 1,771 203.8435 USD
Purchase 1,789 207.7078 USD
Purchase 3,915 207.4135 USD
Purchase 4,520 207.6548 USD
Purchase 4,749 207.6784 USD
Purchase 5,059 203.5960 USD
Purchase 6,823 204.5259 USD
Purchase 6,881 206.5024 USD
Purchase 7,427 204.3577 USD
Purchase 9,693 207.5932 USD
Purchase 12,193 205.7609 USD
Purchase 12,500 206.1091 USD
Purchase 15,195 205.8610 USD
Purchase 24,647 204.6690 USD
Purchase 41,436 206.1574 USD
Sale 1 207.3100 USD
Sale 1 204.7200 USD
Sale 3 207.8866 USD
Sale 6 207.8900 USD
Sale 7 205.6229 USD
Sale 9 207.7500 USD
Sale 10 207.5500 USD
Sale 19 204.0600 USD
Sale 20 207.2200 USD
Sale 24 204.8900 USD
Sale 50 203.1000 USD
Sale 58 203.4100 USD
Sale 79 200.6800 USD
Sale 100 207.4100 USD
Sale 142 207.1094 USD
Sale 194 207.0095 USD
Sale 198 207.6362 USD
Sale 400 202.1250 USD
Sale 826 206.9781 USD
Sale 1,112 203.4853 USD
Sale 1,597 205.0183 USD
Sale 1,912 206.6052 USD
Sale 3,977 203.6116 USD
Sale 4,436 206.0673 USD
Sale 6,203 205.1212 USD
Sale 9,104 207.7100 USD
Sale 9,365 206.0184 USD
Sale 14,716 205.5160 USD
Sale 14,939 206.8283 USD
Sale 19,009 207.6400 USD
Sale 38,854 206.1871 USD
Sale 46,701 204.5665 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure: 28 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201229005481/en/
(https://www.businesswire.com/news/home/20201229005481/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Inter-American Dev - Issue of Debt
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Kitwave Group PLC - Form 8.3 KITWAVE GROUP PLC
Announcement